Phio Pharmaceuticals Corp. (PHIO)
$1.13
$0.01
(0.89%)
As on 28-Aug-2026 16:00EDT
Market cap
$13 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.6
-
Debt to Equity
0
-
Book Value
$1.1
-
EPS
$-1.3
-
Face value
--
-
Shares outstanding
11,617,250
10 Years Aggregate
CFO
$-92.05 Mln
EBITDA
$-92.91 Mln
Net Profit
$-100.81 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Phio Pharmaceuticals (PHIO)
| 7.6 | 7.6 | 2.7 | -44.3 | -62.3 | -64.7 | -69.0 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Phio Pharmaceuticals (PHIO)
| -41.7 | -73.4 | -83.0 | -62.8 | -62.8 | -71.4 | -48.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Phio Pharmaceuticals (PHIO)
|
1.1 | 13.1 | 0.0 | -12.9 | -- | -78.8 | -- | 1.0 |
| 84.9 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 247.9 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 72.1 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.5 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 105.4 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 351.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 533.8 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 600.7 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 344.8 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Phio Pharmaceuticals (PHIO)
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center... Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania. Read more
-
President, CEO & Chairman
Mr. Robert J. Bitterman
-
President, CEO & Chairman
Mr. Robert J. Bitterman
-
Headquarters
King of Prussia, PA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Phio Pharmaceuticals (PHIO)
What is the current share price of Phio Pharmaceuticals Corp (PHIO) Today?
The share price of Phio Pharmaceuticals Corp (PHIO) is $1.13 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Phio Pharmaceuticals Corp (PHIO) has given a return of -62.34% in the last 3 years.
What is the current PB & PE ratio of Phio Pharmaceuticals Corp (PHIO)?
Since, TTM earnings of Phio Pharmaceuticals Corp (PHIO) is negative, P/E ratio is not available.
The P/B ratio of Phio Pharmaceuticals Corp (PHIO) is 1.03 times as on 28-Aug-2026, a 80 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.40 |
0.61 |
2024 |
-0.20 |
0.30 |
2023 |
-0.03 |
0.04 |
2022 |
0.00 |
0.00 |
2021 |
-0.01 |
0.01 |
What is the 52 Week High and Low of Phio Pharmaceuticals Corp (PHIO)?
The 52-week high and low of Phio Pharmaceuticals Corp (PHIO) are Rs 4.19 and Rs 0.81 as of 31-Aug-2026.
What is the market cap of Phio Pharmaceuticals Corp (PHIO)?
Phio Pharmaceuticals Corp (PHIO) has a market capitalisation of $ 13 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Phio Pharmaceuticals Corp (PHIO)?
Before investing in Phio Pharmaceuticals Corp (PHIO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.